Wednesday, March 04, 2020 1:41:12 PM
https://www.cnbc.com/2020/03/04/lawmakers-strike-deal-on-more-than-7-billion-in-emergency-coronavirus-funding.html
Lawmakers strike deal on more than $8 billion in emergency coronavirus funding
U.S. lawmakers on Wednesday unveiled more than $8 billion in emergency funding to address the spread of the deadly coronavirus.
The House was expected to take up the proposal for a vote later Wednesday. Senate leaders hope to vote on the plan soon after.
“Our goal would be to do it this week if we get cooperation,” Senate Majority Leader Mitch McConnell, R-Ky., told reporters Wednesday.
The proposal, which followed days of negotiations on Capitol Hill, provides a total of $8.3 billion to combat the coronavirus outbreak. The bulk of that funding – 85% – will be spent domestically, according to Shelby’s statement.
A House Democratic aide told CNBC that the proposal includes:
More than $3 billion dedicated to the research and development of vaccines, as well as therapeutics and diagnostics;
$2.2 billion in public health funding to aid in prevention, preparedness, and response efforts – including $950 million to support state and local agencies;
Nearly $1 billion to go toward medical supplies, health care preparedness, Community Health Centers and medical surge capacity’
And $1.25 billion to address the coronavirus overseas.
Opti
Lawmakers strike deal on more than $8 billion in emergency coronavirus funding
U.S. lawmakers on Wednesday unveiled more than $8 billion in emergency funding to address the spread of the deadly coronavirus.
The House was expected to take up the proposal for a vote later Wednesday. Senate leaders hope to vote on the plan soon after.
“Our goal would be to do it this week if we get cooperation,” Senate Majority Leader Mitch McConnell, R-Ky., told reporters Wednesday.
The proposal, which followed days of negotiations on Capitol Hill, provides a total of $8.3 billion to combat the coronavirus outbreak. The bulk of that funding – 85% – will be spent domestically, according to Shelby’s statement.
A House Democratic aide told CNBC that the proposal includes:
More than $3 billion dedicated to the research and development of vaccines, as well as therapeutics and diagnostics;
$2.2 billion in public health funding to aid in prevention, preparedness, and response efforts – including $950 million to support state and local agencies;
Nearly $1 billion to go toward medical supplies, health care preparedness, Community Health Centers and medical surge capacity’
And $1.25 billion to address the coronavirus overseas.
Opti
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
Recent INO News
- Positive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China • PR Newswire (US) • 05/21/2026 08:05:00 PM
- INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights • PR Newswire (US) • 05/13/2026 08:05:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 05/08/2026 12:05:00 PM
- INOVIO to Report First Quarter Financial Results on May 13, 2026 • PR Newswire (US) • 05/01/2026 08:05:00 PM
- INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm • PR Newswire (US) • 04/07/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 04/06/2026 07:46:00 AM
- INOVIO Announces Pricing of $17.5 Million Public Offering • PR Newswire (US) • 04/02/2026 12:55:00 PM
- INOVIO Announces Proposed Public Offering • PR Newswire (US) • 04/02/2026 12:05:00 AM
- INOVIO to Participate in Upcoming Scientific Conference • PR Newswire (US) • 04/01/2026 02:29:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/31/2026 01:00:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO • PR Newswire (US) • 03/30/2026 07:47:00 AM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/24/2026 01:00:00 PM
- INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm • PR Newswire (US) • 03/17/2026 01:00:00 PM
- INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/12/2026 08:05:00 PM
- Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/10/2026 01:00:00 PM
- INOVIO to Participate in Upcoming Scientific Conferences • PR Newswire (US) • 03/09/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:55:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:54:42 PM
- INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 • PR Newswire (US) • 03/05/2026 09:05:00 PM
- INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) • PR Newswire (US) • 03/04/2026 01:05:00 PM
- Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO • PR Newswire (US) • 03/03/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:49:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:47:13 PM
